Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus

Influenza A virus (IAV) claims approximately 290,000 to 650,000 lives annually across the globe. Current influenza vaccines are composed of haemagglutinin (HA) and neuraminidase (NA) of the IAV and were shown to be effective in inducing strong and long-lasting HA and NA specific immunities. Howev...

Full description

Saved in:

Bibliographic Details
Main Author:	Ong, Hui Kian
Format:	Thesis
Language:	English
Published:	2018
Subjects:	Influenza Vaccines Influenza A virus
Online Access:	http://psasir.upm.edu.my/id/eprint/83153/1/FPSK%28m%29%202019%2012%20-%20ir.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-upm-ir.83153
record_format	uketd_dc
spelling	my-upm-ir.831532022-01-10T04:28:40Z Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus 2018-11 Ong, Hui Kian Influenza A virus (IAV) claims approximately 290,000 to 650,000 lives annually across the globe. Current influenza vaccines are composed of haemagglutinin (HA) and neuraminidase (NA) of the IAV and were shown to be effective in inducing strong and long-lasting HA and NA specific immunities. However, annual reformulation of the seasonal influenza vaccine is required to catch up the rapid mutations of HA and NA. Effectiveness of a seasonal influenza vaccine could vary considerably from 60 to 90% depending on the similarities of HA and NA proteins of the circulating strains and that of the vaccine strains. Seasonal influenza vaccine effectiveness could be as low as 10% in the case of incorrect prediction of IAV mutations. Therefore, a universal influenza vaccine is in urgent need. Extracellular domain of matrix 2 protein (M2e) of IAV represents a potential candidate for the development of a universal influenza vaccine due to its highly conserved amino acid sequence among IAVs. Nevertheless, M2e is poorly immunogenic in nature and requires a larger carrier to enhance its immunogenicity. Multiple copies of M2e epitopes were previously fused to the C-terminal end of Macrobrachium rosenbergii nodavirus capsid protein (NvC), producing a chimeric protein with three copies of M2e (NvC-M2ex3) which self-assemblies into virus-like particles (VLPs). Although NvC-M2ex3 was demonstrated to be immunogenic in the presence of adjuvants, its protective efficacy has not been investigated in vivo. Therefore, as a continuation of the previous study, induced immune responses, protective efficacy and universality of NvC-M2ex3 against influenza A virus infections were elucidated in this project. BALB/c mice immunised subcutaneously with NvC-M2ex3 were shown to elicit strong M2e specific humoral immune responses even in the absence of adjuvant. When challenged with lethal mouse-adapted H1N1 or H3N2, NvC-M2ex3 immunised mice exhibited 100% survival with reduced morbidity and weight loss in addition to the reduced viral load and viral shedding compared to the control groups. In the histopathological aspect, NvC-M2ex3 immunised mice also experienced mitigated immunopathology in lungs upon influenza A infections. Cytokine responses of the mice immunised with NvC-M2ex3 were found to be different when challenged with different influenza A viruses. A higher level of IFN-γ and IL-12 but no significant difference of IL-6 was detected in the lungs of the NvC-M2ex3 immunised mice compared to the control group upon H1N1 infection. Contrarily, when challenged with H3N2, they exhibited lower level of IFN-γ and IL-6 although a higher level of IL-12 was observed in the lungs. Collectively, this study demonstrated the protective efficacy of NvC-M2ex3 against lethal H1N1 and H3N2 infections. Influenza Vaccines Influenza A virus 2018-11 Thesis http://psasir.upm.edu.my/id/eprint/83153/ http://psasir.upm.edu.my/id/eprint/83153/1/FPSK%28m%29%202019%2012%20-%20ir.pdf text en public masters Universiti Putra Malaysia Influenza Vaccines Influenza A virus Ho, Kok Lian
institution	Universiti Putra Malaysia
collection	PSAS Institutional Repository
language	English
advisor	Ho, Kok Lian
topic	Influenza Vaccines Influenza A virus
spellingShingle	Influenza Vaccines Influenza A virus Ong, Hui Kian Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus
description	Influenza A virus (IAV) claims approximately 290,000 to 650,000 lives annually across the globe. Current influenza vaccines are composed of haemagglutinin (HA) and neuraminidase (NA) of the IAV and were shown to be effective in inducing strong and long-lasting HA and NA specific immunities. However, annual reformulation of the seasonal influenza vaccine is required to catch up the rapid mutations of HA and NA. Effectiveness of a seasonal influenza vaccine could vary considerably from 60 to 90% depending on the similarities of HA and NA proteins of the circulating strains and that of the vaccine strains. Seasonal influenza vaccine effectiveness could be as low as 10% in the case of incorrect prediction of IAV mutations. Therefore, a universal influenza vaccine is in urgent need. Extracellular domain of matrix 2 protein (M2e) of IAV represents a potential candidate for the development of a universal influenza vaccine due to its highly conserved amino acid sequence among IAVs. Nevertheless, M2e is poorly immunogenic in nature and requires a larger carrier to enhance its immunogenicity. Multiple copies of M2e epitopes were previously fused to the C-terminal end of Macrobrachium rosenbergii nodavirus capsid protein (NvC), producing a chimeric protein with three copies of M2e (NvC-M2ex3) which self-assemblies into virus-like particles (VLPs). Although NvC-M2ex3 was demonstrated to be immunogenic in the presence of adjuvants, its protective efficacy has not been investigated in vivo. Therefore, as a continuation of the previous study, induced immune responses, protective efficacy and universality of NvC-M2ex3 against influenza A virus infections were elucidated in this project. BALB/c mice immunised subcutaneously with NvC-M2ex3 were shown to elicit strong M2e specific humoral immune responses even in the absence of adjuvant. When challenged with lethal mouse-adapted H1N1 or H3N2, NvC-M2ex3 immunised mice exhibited 100% survival with reduced morbidity and weight loss in addition to the reduced viral load and viral shedding compared to the control groups. In the histopathological aspect, NvC-M2ex3 immunised mice also experienced mitigated immunopathology in lungs upon influenza A infections. Cytokine responses of the mice immunised with NvC-M2ex3 were found to be different when challenged with different influenza A viruses. A higher level of IFN-γ and IL-12 but no significant difference of IL-6 was detected in the lungs of the NvC-M2ex3 immunised mice compared to the control group upon H1N1 infection. Contrarily, when challenged with H3N2, they exhibited lower level of IFN-γ and IL-6 although a higher level of IL-12 was observed in the lungs. Collectively, this study demonstrated the protective efficacy of NvC-M2ex3 against lethal H1N1 and H3N2 infections.
format	Thesis
qualification_level	Master's degree
author	Ong, Hui Kian
author_facet	Ong, Hui Kian
author_sort	Ong, Hui Kian
title	Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus
title_short	Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus
title_full	Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus
title_fullStr	Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus
title_full_unstemmed	Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus
title_sort	development of a universal influenza a vaccine based on virus-like particles of macrobrachium rosenbergii nodavirus
granting_institution	Universiti Putra Malaysia
publishDate	2018
url	http://psasir.upm.edu.my/id/eprint/83153/1/FPSK%28m%29%202019%2012%20-%20ir.pdf
_version_	1747813352929755136

Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus

Similar Items